Moon Surgical

Moon Surgical is a technology company.

Active

Updated: Feb 17, 2026 ·

Recent News & Mentions

May 1, 2023FundingMoon Surgical - Series B Jun 1, 2022FundingMoon Surgical - Series A May 1, 2022FundingMoon Surgical - Series A Jul 1, 2020FundingMoon Surgical - Seed

Financial History

Moon Surgical has raised $94.0M across 4 funding rounds. Most recently, it raised $55.0M Series B in May 2023.

Total Raised

$94.0M

Valuation

N/A

Funding Rounds Raised

Date	Round	Other Investors
May 1, 2023	$55.0M Series B	99 Startups, Ascension Ventures, Cathay Health, Endeavor Venture Funds, Gradient Ventures, Nazca Ventures, New Enterprise Associates (NEA), Jenny Johnston, Soffinova Partners, Sonder Capital, Colin Cahill, Maurice Ferre, Michael Shoemaker
Jun 1, 2022	$31.0M Series A	99 Startups, Ascension Ventures, Cathay Health, Endeavor Venture Funds, Gradient Ventures, Nazca Ventures, New Enterprise Associates (NEA), Jenny Johnston, Soffinova Partners, Sonder Capital, Colin Cahill, Maurice Ferre, Michael Shoemaker
May 1, 2022	$5.0M Series A	Cathay Health, Endeavor Venture Funds, EQT Life Sciences, New Enterprise Associates (NEA), Qima Ventures, RTW Investments, Soffinova Partners, Sonder Capital
Jul 1, 2020	$3.0M Seed	Cathay Health, Endeavor Venture Funds, New Enterprise Associates (NEA), Soffinova Partners, Sonder Capital

Financial History

Moon Surgical has raised $94.0M across 4 funding rounds.

Total Raised

$94.0M

Valuation

N/A

Deep Dive

High-Level Overview

Moon Surgical is a technology company specializing in advanced robotic systems for laparoscopic surgery. Its flagship product, the Maestro™ System, is designed to assist surgeons in performing minimally invasive soft tissue procedures with enhanced precision, control, and efficiency. The system serves surgeons, operating room staff, and patients by addressing a large market of approximately 18.8 million annual soft tissue surgeries not currently covered by existing robotic platforms. It integrates seamlessly into existing clinical workflows, improving operating room efficiency, reducing procedure times, and enabling alternative labor models. Moon Surgical has demonstrated growth momentum with successful European pilot programs and recent FDA clearance for commercial use in the United States, positioning it for broader adoption in general, bariatric, and gynecologic surgeries[1][2][3].

Origin Story

Founded in 2020, Moon Surgical is headquartered in Paris, France, and San Francisco, California. The company was established with the vision of revolutionizing laparoscopic surgery through robotics and data-driven insights. Anne Osdoit, CEO of Moon Surgical and a partner at Sofinnova Partners' medtech accelerator, MD Start, leads the company. The idea emerged from the need to enhance surgeon capabilities in minimally invasive procedures by providing stable visualization, reliable retraction, and total control. Early traction included CE marking in September 2023 and treatment of over 200 patients across multiple surgical specialties in Europe, which validated the system’s clinical utility and paved the way for FDA clearance and U.S. market entry[1][2].

Core Differentiators

Surgeon-Centric Design: Maestro™ complements surgeons’ laparoscopic skills rather than replacing them, with an ergonomic interface that integrates smoothly into existing workflows[2].
Broad Market Focus: Targets the large and underserved soft tissue laparoscopic surgery market, including general, bariatric, and gynecologic procedures[1][2].
Advanced Technology: Incorporates NVIDIA Holoscan edge computing for real-time AI deployment during surgery, enhancing decision-making and surgical outcomes[1].
Compact and Adaptable: Designed to fit into existing operating rooms without major disruptions, supporting efficiency and alternative labor models[1].
Data Security and Compliance: Holds ISO 27001:2022 and SOC 2 certifications, ensuring robust information security and compliance for its digital surgery ecosystem[4].

Role in the Broader Tech Landscape

Moon Surgical is riding the wave of digital transformation and robotics in healthcare, particularly in minimally invasive surgery. The timing is favorable due to increasing demand for laparoscopic procedures driven by aging populations and rising obesity rates, especially in bariatrics—a market growing at a 9% CAGR globally. The company’s focus on soft tissue surgeries fills a significant gap left by existing robotic systems that primarily target other surgical areas. By integrating AI and data analytics into the operating room, Moon Surgical is contributing to the broader trend of smart, connected healthcare environments that improve patient outcomes and operational efficiency[1][2][4].

Quick Take & Future Outlook

Moon Surgical is poised for rapid growth as it expands commercial programs in the U.S. following FDA clearance and continues to scale its presence in Europe. Future trends shaping its journey include the increasing adoption of AI in surgery, demand for cost-effective robotic solutions, and the digitalization of operating rooms. As the Maestro System evolves with enhanced digital capabilities and data-driven insights, Moon Surgical’s influence is likely to grow, potentially setting new standards for collaborative robotic surgery and transforming surgical care delivery worldwide[1][4].

Sources

Frequently Asked Questions

How much funding has Moon Surgical raised?

Moon Surgical has raised $94.0M in total across 4 funding rounds.

Who are Moon Surgical's investors?

Moon Surgical's investors include 99 Startups, Ascension Ventures, Cathay Health, Endeavor Venture Funds, Gradient Ventures, Nazca Ventures, New Enterprise Associates (NEA), Jenny Johnston, Soffinova Partners, Sonder Capital, Colin Cahill, Maurice Ferre.